Intelligent Investor

Medlab Clinical Limited (ASX: MDC) - Announcements

- Current share price for MDC : $6.600

ASX company news and announcements for Medlab Clinical Limited (MDC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medlab Clinical Limited (MDC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medlab Clinical Limited (MDC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medlab Clinical Limited (MDC)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$15 Auditor Appointment/Resignation 2 Apr 2024 9:05AM $6.600 $6.600 $6.600 fallen by 0%
$15 Final Director's Interest Notice 28 Mar 2024 8:38AM $6.600 $6.600 $6.600 fallen by 0%
$15 Initial Director's Interest Notice 28 Mar 2024 8:38AM $6.600 $6.600 $6.600 fallen by 0%
$15 MDC Board of Directors Composition Update 28 Mar 2024 8:37AM $6.600 $6.600 $6.600 fallen by 0%
$15 MDC ASX Release Change of Share Registry Provider 29 Feb 2024 1:43PM $6.600 $6.600 $6.600 fallen by 0%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 12:36PM $6.600 $6.600 $6.600 fallen by 0%
$15 Medlab Settlement of Share Sale Deed 15 Jan 2024 3:15PM $6.600 $6.600 $6.600 fallen by 0%
$15 MDC HY23 Interim Report 9 Jan 2024 12:03PM $6.600 $6.600 $6.600 fallen by 0%
$15 MDC 2023 EGM Voting Results 22 Dec 2023 3:01PM $6.600 $6.600 $6.600 fallen by 0%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 8 Dec 2023 6:15PM $6.600 $6.600 $6.600 fallen by 0%
$15 Notice of Extraordinary General Meeting / Proxy Form 22 Nov 2023 8:29PM $6.600 $6.600 $6.600 fallen by 0%
$15 Shareholder Update - Restructuring Transaction 9 Nov 2023 3:17PM $6.600 $6.600 $6.600 fallen by 0%
$15 Medlab Update to Shareholders 12 Sep 2023 4:37PM $6.600 $6.600 $6.600 fallen by 0%
$15 Suspension from Official Quotation - Annual Listing Fees 22 Aug 2023 9:55AM $6.600 $6.600 $6.600 fallen by 0%
$15 Medlab Update to Shareholders 3 Aug 2023 2:03PM $6.600 $6.600 $6.600 fallen by 0%
$15 Medlab Update to Shareholders 7 Jun 2023 10:22AM $6.600 $6.600 $6.600 fallen by 0%
$15 Response to ASX Query 23 Mar 2023 3:45PM $6.600 $6.600 $6.600 fallen by 0%
$15 Medlab Update to Shareholders 21 Mar 2023 10:39AM $6.600 $6.600 $6.600 fallen by 0%
$15 Final Director's Interest Notice 16 Mar 2023 8:24AM $6.600 $6.600 $6.600 fallen by 0%
$15 Initial Director's Interest Notice 16 Mar 2023 8:24AM $6.600 $6.600 $6.600 fallen by 0%
$15 Company Status and Board Composition Updates 16 Mar 2023 8:23AM $6.600 $6.600 $6.600 fallen by 0%
$15 Appointment of External Consultants to Medlab 6 Mar 2023 4:27PM $6.600 $6.600 $6.600 fallen by 0%
$15 Suspension from Official Quotation 27 Feb 2023 11:32AM $6.600 $6.600 $6.600 fallen by 0%
$15 Trading Halt 23 Feb 2023 9:34AM $6.600 $6.600 $6.600 fallen by 0%
$15 Aust ODC Approves NanaDol Export for UK Use 7 Feb 2023 10:14AM $7.000 $6.600 $6.600 fallen by 5.71%

1 - 25 of 415 results

Page 1 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.